By binding to vascular endothelial growth factor-A (VEGF-A), it blocks VEGF-A-induced angiogenesis, consequently inhibiting tumor metastasis and prolonging patients’ survival (Midgley & Kerr, 2005). Here, VEGFA is linked to neoplasm.